Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Evolent Health, Inc.
EVH
NYSE·Healthcare·Medical - Healthcare Information Services·Mkt cap $645.6M
$5.71
▼ -0.52%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$2.10 - $12.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 51.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary Identifi technology platform that aggregates data, manages workflows, and enables patient engagement at scale
- Dual expertise spanning both payer and provider perspectives, enabling comprehensive end-to-end solutions
- Established relationships with major health plans and healthcare systems built over 12+ years of operations
- Specialized clinical capabilities in high-cost specialty care areas (oncology and cardiology) with proven cost management track records
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Industry-wide shift from fee-for-service to value-based care models creating sustained demand for transition solutions
Value
Fairly valued vs Healthcare IT & Services peers
Momentum
Hot
+155.1% over 3m
Quality
Thin
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying EVH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of -$0.02 vs -$0.05 consensus (+60.0% surprise). Revenue of $496.2M vs $534.0M expected (-7.1%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+60.0%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
+16%
-24%
-31%
-23%
-28%
+3%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$647.1M
$621.4M
$646.5M
$483.6M
$444.3M
$479.5M
$468.7M
$496.2M
Margins · last 8Q
Gross
—
Operating
—
Profit
-5.4%
Wall Street consensus
9 analysts · 78% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
78%
Hold
22%
Sell
0%
Median Price Target
$6.00
▲ +5.1% vs $5.71
Latest: Citi · May 15, 2026
1 analyst covering